Zai Lab Announces Potential Pricing for IPO
Biopharmaceutical company Zai Lab intends to price its 8 million shares in the range that results in an initial public offering valued up to more than $165 million.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 157
Why Alnylam Pharmaceuticals Is Wednesday’s Top Stock
Alnylam Pharmaceuticals saw its shares make a handy gain on Wednesday after the firm gave an update on its late-stage trial in patients with hereditary ATTR amyloidosis with polyneuropathy.
Gallup Poll Finds Rates of Regular Exercise Rising in US Communities
The United States may be among the most obese nations in the world, but there is good news when it comes to those who exercise in America.
MediWound Secondary Capitalizes on 2017 Success
Biotech companies may attempt a secondary offering after seeing a run in the share price. So now seems the as good a time as any for MediWound to capitalize in 2017.
Will Dimension Therapeutics Take the New and Bigger Buyout Offer?
Dimension Therapeutics saw one of the largest gains on the day after it came to light that the firm received an acquisition offering from Ultragenyx Pharmaceutical.
Deciphera Pharma Takes Another Step Closer to IPO
Deciphera Pharmaceuticals expects to price more than 6 million shares in a range that results in an initial public offering valued up to more than $122 million.
Pluristem Wins Key FDA Approval
Shares of Pluristem Therapeutics saw a handy gain early Monday after the company said it had received a key update from the FDA.
How Much Does Modern Medicine Cut the Number of Early Deaths?
Modern medicine is succeeding in reducing the number of early deaths, according to a recent study.
Why Nabriva Shares Are Doubling
Nabriva Therapeutics watched its shares more than double to kick off the week after the firm announced results from its late-stage trial in patients with community-acquired bacterial pneumonia.
Nightstar Therapeutics Announces Potential Pricing for IPO
Nightstar Therapeutics intends to price more than 5 million shares in a range that results in an initial public offering valued up to more than $92 million.
T2 Biosystems Prices Secondary Offering
T2 Biosystems saw its shares drop handily early on Friday after the firm announced that it would be pricing its secondary offering.
Cities and States With the Most (and Least) Uninsured Residents
A new analysis from WalletHub ranks 547 U.S. cities and all 50 states on the number of Americans who lack health insurance. Over the past year, the percentage has of those without insurance has…
Krystal Biotech Gears Up for IPO
Gene therapy company Krystal Biotech expects to price 3 million shares so that the entire offering is valued up to nearly $38 million.
Why Pfizer Is Pushing the Dow to All-Time Highs
Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day.
What You Need to Know About the Tenet Healthcare Sale
Tenet Healthcare watched its shares make a handy gain early on Thursday after The Wall Street Journal announced that it was exploring the possibility of a sale.